thrombocythemia


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to thrombocythemia: hydroxyurea, thrombocytosis

thrombocythemia

 [throm″bo-si-the´me-ah]
essential thrombocythemia (hemorrhagic thrombocythemia) a clinical syndrome with repeated spontaneous hemorrhages, either external or into the tissues, and a greatly increased number of circulating platelets, considered one of the myeloproliferative disorders. Called also megakaryocytic leukemia.

throm·bo·cy·to·sis

(throm'bō-sī-tō'sis),
An increase in the number of platelets in the circulating blood.
Synonym(s): thrombocythemia
[thrombocyte + G. -osis, condition]

thrombocythemia

/throm·bo·cy·the·mia/ (throm″bo-si-the´me-ah) thrombocytosis.
essential thrombocythemia , hemorrhagic thrombocythemia a syndrome of repeated spontaneous hemorrhages, either external or into the tissues, and greatly increased number of circulating platelets.

thrombocythaemia, thrombocythemia

throm·bo·cy·to·sis

(throm'bō-sī-tō'sis)
An increase in the number of platelets in the circulating blood.
Synonym(s): thrombocythemia.
[thrombocyte + G. -osis, condition]

throm·bo·cy·to·sis

, thrombocythemia (throm'bō-sī-tō'sis, -sī-thēmē-ă)
An increase in the number of platelets in the circulating blood.
Synonym(s): thrombocythaemia.
[thrombocyte + G. -osis, condition]

thrombocythemia (throm´bōsīthē´mēə),

n an increase in the number of circulating blood platelets.

thrombocythemia

a fixed increase in the number of circulating blood platelets.

essential thrombocythemia, hemorrhagic thrombocythemia
a clinical syndrome with repeated spontaneous hemorrhages, either external or into the tissues, and greatly increased number of circulating platelets.
References in periodicals archive ?
The report reviews pipeline therapeutics for Essential Thrombocythemia by companies and universities/research institutes based on information derived from company and industry-specific sources
Long-term use of anagrelide in young patients with essential thrombocythemia.
The World Health Organization (WHO) diagnostic criteria for PV, essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF) were revised after the discovery of JAK2 mutations in 2008 (for example: JAK2 V617F and JAK2 exon 12 mutations in virtually all patients with PV.
The 1950 hypothesis of Dameshek was confirmed by Vainchenker in France by the discovery in 2005 of the acquired JAK2V617F mutation as the cause of 3 phenotypes of classical inyeloproliferative neoplasia: essential thrombocythemia.
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.
Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia.
Erythromelalgia is characterized by recurrent attacks of burning pain and warmth and erythema of the extremities, and it can be associated with myeloproliferative disorders and thrombocythemia.
A two day workshop on the use of PCR technology for early diagnosis, monitoring and management of Beta Thalassemia and Mutations in JAK2 that have been implicated in polycythemia vera, essential thrombocythemia, myelofibrosis as well as other myeloproliferative disorders was conducted by joint effort of Departments of Biochemistry, Hematology and Molecular Pathology on 20th and 21st Feb.
About 20% of secondary erythromelalgia cases occur in patients with myeloproliferative diseases, such as polycythemia rubra vera and essential thrombocythemia.
Primary thrombocytosis (also called essential thrombocythemia, ET) is caused by autonomous production of platelets unregulated by the physiologic feedback mechanism to keep the count within the reference range.